Xeris Biopharma Holdings, Inc. (XERS)
USD 3.25
(-4.69%)
USD 3.25
(-4.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 163.91 Million | 110.24 Million | 110.24 Million | 49.59 Million | 20.15 Million | 2.46 Million |
| Cost of Revenue | 28.64 Million | 22.63 Million | 22.63 Million | 13.31 Million | 9.32 Million | 42 Thousand |
| Gross Profit | 135.26 Million | 87.61 Million | 87.61 Million | 36.27 Million | 10.82 Million | 2.42 Million |
| Operating Expenses | 168.43 Million | 169.55 Million | 169.55 Million | 151.42 Million | 94.37 Million | 61.76 Million |
| Selling, General and Administrative Expenses | 146.09 Million | 137.74 Million | 137.74 Million | 125.71 Million | 73.73 Million | 21.11 Million |
| Research and Development Expenses | 22.34 Million | 20.96 Million | 20.96 Million | 25.16 Million | 20.92 Million | 40.65 Million |
| Other Expenses | 10.84 Million | -14.14 Million | 10.84 Million | 550 Thousand | -280 Thousand | - |
| Cost and Expenses | 207.92 Million | 192.18 Million | 192.18 Million | 164.74 Million | 103.7 Million | 61.8 Million |
| Operating Income | -44.01 Million | -81.94 Million | -81.94 Million | -115.15 Million | -83.54 Million | -59.34 Million |
| Interest Expense | 26.6 Million | 15.32 Million | 15.32 Million | 7.18 Million | 10.66 Million | 2.54 Million |
| Income Tax Expense | -1.24 Million | -1.42 Million | -1.42 Million | -110 Thousand | -110 Thousand | 1.8 Million |
| Earnings before Tax | -63.5 Million | -96.08 Million | -96.08 Million | -122.72 Million | -91.25 Million | -60.08 Million |
| Net Income | -62.25 Million | -94.66 Million | -94.66 Million | -122.72 Million | -91.14 Million | -60.08 Million |
| Earnings Per Share Basic | -0.45 | -0.70 | -1.20 | -2.88 | -3.49 | -4.99 |
| Earnings Per Share Diluted | -0.45 | -0.70 | -1.20 | -2.88 | -3.49 | -4.99 |
| Weighted Average Shares Outstanding | 137.67 Million | 135.62 Million | 79.02 Million | 42.64 Million | 26.11 Million | 12.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 137.67 Million | 135.62 Million | 79.02 Million | 42.64 Million | 26.11 Million | 12.04 Million |
| Gross Margin | 0.83 | 0.79 | 0.79 | 0.73 | 0.54 | 0.98 |
| EBIT Margin | -0.14 | -0.64 | -0.64 | -2.31 | -4.00 | -23.42 |
| Profit Margin | -0.38 | -0.86 | -0.86 | -2.47 | -4.52 | -24.37 |
| EBITDA | -23.73 Million | -69.31 Million | -113.66 Million | -80.07 Million | -117.79 Million | -57.21 Million |
| Earnings Before Tax Margin | -0.27 | -0.74 | -0.74 | -2.32 | -4.15 | -24.07 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 FY | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 48.06 Million | 40.63 Million | 163.91 Million | 44.39 Million | 48.32 Million | 38 Million |
| Cost of Revenue | 10.5 Million | 8.68 Million | 39.48 Million | 10.28 Million | 8.2 Million | 7.55 Million |
| Gross Profit | 37.56 Million | 31.95 Million | 124.42 Million | 34.1 Million | 40.11 Million | 30.45 Million |
| Operating Expenses | 45.75 Million | 46.2 Million | 168.43 Million | 43.95 Million | 42.32 Million | 46.43 Million |
| Selling, General and Administrative Expenses | 39.99 Million | 38.38 Million | - | 37.56 Million | 37.28 Million | 37.63 Million |
| Research and Development Expenses | 5.75 Million | 7.82 Million | - | 6.38 Million | 5.03 Million | 6.08 Million |
| Other Expenses | 2.7 Million | - | - | 15.7 Million | -7.61 Million | -4.53 Million |
| Cost and Expenses | 56.25 Million | 54.88 Million | 207.92 Million | 54.23 Million | 53.23 Million | 53.98 Million |
| Operating Income | -8.18 Million | -14.24 Million | -44.01 Million | -9.84 Million | -4.91 Million | -15.97 Million |
| Interest Expense | 7.96 Million | 7.03 Million | 26.6 Million | 7.01 Million | -6.84 Million | 6.52 Million |
| Income Tax Expense | 749 Thousand | 307 Thousand | -1.24 Million | -236 Thousand | 338 Thousand | -675 Thousand |
| Earnings before Tax | -14.25 Million | -18.67 Million | -63.5 Million | -13.62 Million | -12.52 Million | -20.51 Million |
| Net Income | -15 Million | -18.98 Million | -62.25 Million | -13.39 Million | -12.18 Million | -19.84 Million |
| Earnings Per Share Basic | -0.10 | -0.14 | - | -0.10 | -0.09 | -0.14 |
| Earnings Per Share Diluted | -0.10 | -0.14 | - | -0.10 | -0.09 | -0.14 |
| Weighted Average Shares Outstanding | 148.34 Million | 140.51 Million | 137.67 Million | 138.12 Million | 138.05 Million | 137.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 148.34 Million | 140.51 Million | 137.67 Million | 138.12 Million | 138.05 Million | 137.33 Million |
| Gross Margin | 0.78 | 0.79 | 0.76 | 0.77 | 0.83 | 0.80 |
| EBIT Margin | -0.10 | -0.27 | - | -0.15 | -0.10 | -0.35 |
| Profit Margin | -0.31 | -0.47 | -0.38 | -0.30 | -0.25 | -0.52 |
| EBITDA | -5.03 Million | -11.03 Million | - | -6.58 Million | -4.91 Million | -13.26 Million |
| Earnings Before Tax Margin | -0.17 | -0.35 | -0.27 | -0.22 | -0.10 | -0.42 |
FCNCB
NCLIND
ALTX
KARW
2914
OKDAV